Vaxxinity Receivables

Vaxxinity (VAXX) currently reports a receivables of $410K as of December 2023. That compares with $410K in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Vaxxinity's receivables history and peer comparisons.

Vaxxinity's receivables was unchanged from $410K to $410K — essentially flat versus a year earlier (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vaxxinity reported $410K in receivables as of December 2023. That compares with $410K in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $410K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vaxxinity, and consider following VAXX for alerts when major investors trade the stock.